COPD Assessment and Management Bundle Versus Usual Care
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Chronic Obstructive Pulmonary Disease, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 40 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2013 |
| End Date: | December 2017 |
Comparative Effectiveness of COPD Assessment and Management Bundle Versus Usual Care in Patients Suspected of Having COPD
Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory (lung) disease
that makes it harder to breathe over time. To date, there is no cure for COPD, but it can be
managed when diagnosed and proper medical care is provided.
The purpose of this study is to determine if diagnosis and guided therapy with the use of
spirometry is related to better patient outcomes (the condition of a patient's health)
compared to usual care which may or may not include the use of spirometry. Spirometry is a
standardized test used in medical practice that measures how much air your lungs can hold
and how forcefully you can breathe out.
For this study, the investigators will compare two groups: 1) intervention (treatment) group
and 2) usual care group (control). The intervention group will have a spirometry test and
the results will be provided to the primary care physician. The usual care group will not
initially have a spirometry test. Both groups will be followed for outcomes.
that makes it harder to breathe over time. To date, there is no cure for COPD, but it can be
managed when diagnosed and proper medical care is provided.
The purpose of this study is to determine if diagnosis and guided therapy with the use of
spirometry is related to better patient outcomes (the condition of a patient's health)
compared to usual care which may or may not include the use of spirometry. Spirometry is a
standardized test used in medical practice that measures how much air your lungs can hold
and how forcefully you can breathe out.
For this study, the investigators will compare two groups: 1) intervention (treatment) group
and 2) usual care group (control). The intervention group will have a spirometry test and
the results will be provided to the primary care physician. The usual care group will not
initially have a spirometry test. Both groups will be followed for outcomes.
The purpose of this study is to determine if diagnosis and guided therapy with the use of
spirometry is related to better patient associated outcomes compared to usual care which may
or may not include the use of spirometry. To do this, we propose a comparative effectiveness
trial of introducing a COPD assessment and management bundle targeted to primary care
providers for patients suspected of having COPD versus usual care.
spirometry is related to better patient associated outcomes compared to usual care which may
or may not include the use of spirometry. To do this, we propose a comparative effectiveness
trial of introducing a COPD assessment and management bundle targeted to primary care
providers for patients suspected of having COPD versus usual care.
Inclusion Criteria:
Patients, male and female, who are at least 40 years of age, receive primary treatment at
the University of Illinois , and with any one of the following:
New Diagnosis
Inpatient or emergency department setting
1. New physician-diagnosis of COPD and/or new physician-diagnosis of asthma with a ≥10
pack year smoking without a spirometry 4 weeks or more after discharge from diagnosis
setting.
Outpatient setting
2. A new physician diagnosis of COPD within the past 6 months prior to their visit,
without a spirometry or with a normal spirometry within the past 5 years prior to the
diagnosis to the time of their visit.
3. A new physician diagnosis of asthma within past 6 months and a ≥10 pack year smoking
history prior to their visit, without a diagnosis of COPD, without a spirometry or
with a pre-bronchodilator spirometry with evidence of obstruction within the past 5
years prior to the diagnosis to the time of their visit.
4. Any patient with an existing physician-diagnosis of asthma within the past 2 years
but > 6 months prior to the time of their visit and a ≥10 pack year smoking history,
without a diagnosis of COPD, using a respiratory medication in the past year, and no
spirometry on record or had a pre-bronchodilator spirometry with evidence of
obstruction on record for at least the past 5 years.
Existing Diagnosis
5. Any patient with an existing physician-diagnosis of COPD within the past 2 years but
> 6 months prior to the time of their visit, and using a respiratory medication in
the past year but no spirometry on record or had a spirometry without evidence of
chronic obstruction in the past 5 years.
Exclusion Criteria:
1. Unable to perform adequate spirometry (e.g. muscle weakness, tracheostomy, cognitive
dysfunction, mental retardation or other psychiatric disorders)
2. Non-English speaking
3. Pregnancy
4. Any patient planning to move away from the city within the next year.
5. Seen by a pulmonary specialist in the past 3 years.
6. Any terminal illness with a life expectancy of <6 months (e.g. hospice care,
malignancies)
7. Any patient with a physician diagnosis of COPD and had a pre or post-bronchodilator
spirometry with evidence of chronic obstruction on record.
We found this trial at
1
site
Univ of Illinois A major research university in the heart of one of the world's...
Click here to add this to my saved trials
